T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
89 hedge funds and large institutions have $203M invested in T2 Biosystems, Inc in 2018 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.
550% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 8
98% more funds holding
Funds holding: 45 → 89 (+44)
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
65% more capital invested
Capital invested by funds: $123M → $203M (+$80.3M)
61% more call options, than puts
Call options by funds: $2.36M | Put options by funds: $1.47M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.6M |
| 2 |
Millennium Management
New York
|
+$6.76M |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$5.73M |
| 4 |
Renaissance Technologies
New York
|
+$4.93M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tiger Management
New York
|
-$7.7M |
| 2 |
LIM
Lagoda Investment Management
New York
|
-$6.3M |
| 3 |
SH
Sandia Holdings
Greenwich,
Connecticut
|
-$3.53M |
| 4 |
Morgan Stanley
New York
|
-$1.14M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$911K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MAM
101
Meeder Asset Management
Dublin,
Ohio
| $333 | – | – | – |
|
|
SH
102
Sandia Holdings
Greenwich,
Connecticut
| – | -$3.53M | -109 | Closed |
|
|
TEE
103
Tibra Equities Europe
London,
United Kingdom
| – | -$338K | -10 | Closed |
|
|
ECM
104
Element Capital Management
New York
| – | -$200K | -6 | Closed |
|
|
VF
105
Virtu Financial
New York
| – | -$175K | -5 | Closed |
|
|
BCM
106
BlueCrest Capital Management
St Helier,
Jersey
| – | -$96K | -3 | Closed |
|
|
JG
107
Jefferies Group
New York
| – | -$106K | -3 | Closed |
|
108
Walleye Trading
New York
| – | -$87K | -3 | Closed |
|
TTOO Hedge Fund Activity: Q2 2018 in Review
89 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2018, worth a combined $203M — up 65% from $123M a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new TTOO positions and 8 closed out — a net gain of 44 holders — while 17 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $12.6M. The largest seller was Tiger Management, cutting an estimated $7.7M.
- 89 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2018, up from 45 in Q1 2018.
- Funds reported $203M of T2 Biosystems, Inc stock for Q2 2018, up 65% quarter-over-quarter.
- 52 funds opened new T2 Biosystems, Inc positions in Q2 2018 and 8 closed out, a net change of +44 holders.
- The largest T2 Biosystems, Inc buyer in Q2 2018 was BlackRock, an estimated $12.6M added.
- The largest T2 Biosystems, Inc seller in Q2 2018 was Tiger Management, an estimated $7.7M sold.
Based on aggregated 13F filings for Q2 2018.